Original citation: J Clin Invest. 2011;121(3):880–892. https://doi.org/10.1172/JCI40433
Citation for this retraction: J Clin Invest. 2019;129(4):1804. https://doi.org/10.1172/JCI128836
The Editorial Board has recently been informed that the NIH examined the primary data from pheochromocytoma patients used to construct Table 4. Evidence shows that the data on the pheochromocytoma patients in Table 4 are not reliable. Due to this finding, the JCI is retracting this article.
Niamh X. Cawley, Stephen M. Hewitt, Hong Lou, Thanh Huynh, and Karel Pacak have agreed with the Journal’s decision to retract the paper. Terence K. Lee, Saravana R.K. Murthy, Savita Dhanvantari, Tracy Lau, Stephanie Ma, and Irene O. Ng dissent from the retraction. Ronnie T. Poon and Robert A. Wesley could not be reached, and Y. Peng Loh abstained from commenting.
Version 1. 03/18/2019
Electronic publication
Version 2. 04/01/2019
Print issue publication